DeutschNewstral
Article
Ppacbiztimes.com on 2018-08-30 01:36
Europeans OK expanded use of Amgen’s Blincyto
Related news
- PEuropeans OK use of Amgen’s Repatha to prevent heart attacks, strokespacbiztimes.com
FDA Approves Expanded Use of Amgen’s Enbrel®jdsupra.com- PEuropeans recommend approval of Amgen’s biosimilar of AbbVie’s Humirapacbiztimes.com
Novartis wins US OK for biosimilar version of Amgen’s EnbrelDenver Post- PEuropeans nix Amgen’s Evenity over negative trial resultspacbiztimes.com
- PFDA approves biosimilar of Amgen’s Enbrelpacbiztimes.com
- PFDA approves biosimilar of Amgen’s Neulastapacbiztimes.com
- FDA Approves Amgen’s Biosimilar of Avastin®jdsupra.com
FDA Approves Amgen’s Biosimilar Version of Humirawsj.com- Analysis of Amgen’s complaint against Sandoz in pegfilgrastim litigationjdsupra.com
- PJudge blocks sale of competitor for Amgen’s Enbrelpacbiztimes.com
- Summary of Amgen’s Opening and Responsive Brief in Sandoz v. Amgenjdsupra.com
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon TherapeuticsThe New York Times- Amgen’s Neulasta Declaratory Judgment Action Dismissed in District of New Jerseyjdsupra.com
- MFTC sues to block Amgen’s acquisition of Horizon Therapeutics2 min readmarketwatch.com
- PFTC settles lawsuit, paves way for Amgen’s $28B purchase of Horizon Therapeuticspacbiztimes.com
- PAmgen’s ongoing patent lawsuitpacbiztimes.com
- BWhy Amgen’s Earnings Disappointedbarrons.com
- PFDA approves Amgen’s Blincytopacbiztimes.com
- PFDA approves Amgen’s Kyprolispacbiztimes.com